Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-07-21
DOI
10.1111/jgh.15631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future
- (2021) Geert R D'Haens et al. GUT
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Women have Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
- (2020) Maya Balakrishnan et al. Clinical Gastroenterology and Hepatology
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
- (2020) Franziska Wandrer et al. Cell Death & Disease
- Commentary: nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Insulin resistance and NAFLD: relationship with intrahepatic iron and serum TNF-α using 1H MR spectroscopy and MRI
- (2019) Jose Luis Martin-Rodriguez et al. DIABETES & METABOLISM
- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis
- (2019) Sumit Kar et al. PLoS One
- Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
- (2019) Alessandro Federico et al. Oxidative Medicine and Cellular Longevity
- NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis
- (2018) Wenwen Gao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pathways underlying iron accumulation in human nonalcoholic fatty liver disease
- (2018) Elmar Aigner et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients
- (2016) Ahmed Abdel-Razik et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease
- (2016) Veeral Ajmera et al. HEPATOLOGY
- Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines
- (2016) Raika Jamali et al. MEDICINE
- Nonalcoholic fatty future disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adipokines in nonalcoholic fatty liver disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Plasma IL-1 receptor antagonist levels correlate with the development of non-alcoholic steatohepatitis
- (2015) Tim Hendrikx et al. Biomarkers in Medicine
- Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis
- (2015) Marta B. Afonso et al. CLINICAL SCIENCE
- Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2015) Stergios A. Polyzos et al. DIABETOLOGIA
- Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
- (2015) Venkatanarayana Gangarapu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease
- (2015) Johannie du Plessis et al. GASTROENTEROLOGY
- Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease
- (2015) Shweta Kapil et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH
- (2015) Salih Boga et al. Metabolic Syndrome and Related Disorders
- Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity
- (2015) Michael Georgoulis et al. NUTRITION RESEARCH
- Altered gut–liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver
- (2015) Valerio Nobili et al. THORAX
- Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
- (2015) Luisa Vonghia et al. PLoS One
- Sex-specific effect of BMI on insulin sensitivity and TNF-α expression
- (2014) Antonella Marucci et al. ACTA DIABETOLOGICA
- Novel Role of IL-13 in Fibrosis Induced by Nonalcoholic Steatohepatitis and Its Amelioration by IL-13R-Directed Cytotoxin in a Rat Model
- (2014) T. Shimamura et al. JOURNAL OF IMMUNOLOGY
- Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation
- (2014) Mario Reis Alvares-da-Silva WORLD JOURNAL OF GASTROENTEROLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
- (2012) Stephanie Coulon et al. CYTOKINE
- Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model*
- (2012) Marcela Aparicio-Vergara et al. HEPATOLOGY
- Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis
- (2012) Nathalie Carvalho Leite et al. HEPATOLOGY RESEARCH
- Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
- (2012) Annie-Carole Tosello-Trampont et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anthropometric Measures of Visceral and Subcutaneous Fat Are Important in the Determination of Metabolic Dysregulation in Boys and Girls at Risk for Nonalcoholic Fatty Liver Disease
- (2012) Diana R. Mager et al. NUTRITION IN CLINICAL PRACTICE
- Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine
- (2011) Satish C. Kalhan et al. CLINICAL SCIENCE
- Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients
- (2011) Edith Koehler et al. LIVER INTERNATIONAL
- Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8
- (2010) Ahmed Abu Shanab et al. DIGESTIVE DISEASES AND SCIENCES
- Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children
- (2010) Anna Alisi et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2010) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pro- and Anti-inflammatory Cytokines in Steatosis and Steatohepatitis
- (2010) Fabiola Rabelo et al. OBESITY SURGERY
- Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
- (2010) Adeline Bertola et al. PLoS One
- Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?
- (2009) Marilena Durazzo et al. JOURNAL OF GASTROENTEROLOGY
- Triglyceride Levels and Not Adipokine Concentrations Are Closely Related to Severity of Nonalcoholic Fatty Liver Disease in an Obesity Surgery Cohort
- (2009) Sangeeta R. Kashyap et al. Obesity
- Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis
- (2008) Annarosa Floreani et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
- (2008) Zobair M. Younossi et al. OBESITY SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now